CENTRAL TRUST Co Sells 2,925 Shares of GlaxoSmithKline plc (NYSE:GSK) – Riverton Roll
CENTRAL TRUST Co lessened its position in GlaxoSmithKline plc (NYSE:GSK) by 19.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,233 shares of the pharmaceutical company’s stock after selling 2,925 shares during the period. Fisher Asset Management LLC now owns 15,267,588 shares of the pharmaceutical company’s stock valued at $651,621,000 after purchasing an additional 1,412,368 shares in the last quarter. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the stock.